Redeye: Carasent - Solid ARR despite lowered target
Refinitiv閱讀少於1分鐘
Redeye updates its Base Case and forecasts following the Q2 report, showing solid underlying business momentum despite the lowered 2025 target.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/
登入或建立一個永久免費帳戶來閱讀此新聞